Literature DB >> 9453073

Stereoselective disposition of suspensions of conventional and wax-matrix sustained release ibuprofen microspheres in rats.

C M Adeyeye1, F F Chen.   

Abstract

PURPOSE: The aim of the study is to evaluate stereoselective in vivo disposition of suspensions of conventional and wax-matrix sustained release ibuprofen microspheres in rats.
METHODS: Male wistar rats were dosed i.v. with 20 mg/kg, or orally with conventional suspension, and three suspension formulations of sustained release microspheres (having three different particle sizes) of racemic ibuprofen. Blood samples were analyzed stereoselectively by reverse phase HPLC.
RESULTS: The mean Cmax for (S)- and (R)-ibuprofen decreased with increased particle size of the drug or microspheres in the suspension dosage forms, while the Tmax increased with increased particle size. The mean S/R ratio (AUC0-48) of the suspensions decreased with increase in particle size of the drug or microspheres and these ratios (for both conventional and sustained formulations) were higher than that of the i.v., an indication of presystemic inversion. Decrease in the ratios with increased particle size is suggestive of formulation dependent inversion. The plasma concentration-time data of the sustained release formulations showed bimodal profiles, irrespective of the particle size of the microspheres. The second peak observed after 8 hours is indicative of colonic absorption.
CONCLUSIONS: Stereoselective disposition of ibuprofen microspheres showed higher bioavailability compared to the conventional suspension. Bimodal disposition is influenced by dosage form while presystemic inversion is both site-specific, and dosage form dependent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9453073     DOI: 10.1023/a:1012104518554

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Isomeric inversion of ibuprofen (R)-enantiomer in humans.

Authors:  D G Kaiser; G J Vangiessen; R J Reischer; W J Wechter
Journal:  J Pharm Sci       Date:  1976-02       Impact factor: 3.534

2.  Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.

Authors:  C M Adeyeye; J C Price
Journal:  J Microencapsul       Date:  1997 May-Jun       Impact factor: 3.142

3.  Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies.

Authors:  C M Adeyeye; J C Price
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

4.  Acute gastrointestinal toxic effects of suspensions of unencapsulated and encapsulated ibuprofen in rats.

Authors:  C M Adeyeye; J D Bricker; V D Vilivalam; W I Smith
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

5.  Ibuprofen stereoisomer hepatic clearance and distribution in normal and fatty in situ perfused rat liver.

Authors:  J W Cox; S R Cox; G VanGiessen; M J Ruwart
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

6.  Stereoselective systemic disposition of ibuprofen enantiomers in the dog.

Authors:  H Y Ahn; G L Amidon; D E Smith
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

7.  Improved high-performance liquid chromatographic assay method for the enantiomers of ibuprofen.

Authors:  M R Wright; S Sattari; D R Brocks; F Jamali
Journal:  J Chromatogr       Date:  1992-12-02

8.  Stereoselective disposition of ibuprofen enantiomers in man.

Authors:  E J Lee; K Williams; R Day; G Graham; D Champion
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

9.  Stereospecific high-performance liquid chromatographic assay of ibuprofen: improved sensitivity and sample processing efficiency.

Authors:  C H Lemko; G Caillé; R T Foster
Journal:  J Chromatogr       Date:  1993-09-22

10.  Stereospecific inversion of (R)-(-)-benoxaprofen in rat and man.

Authors:  R G Simmonds; T J Woodage; S M Duff; J N Green
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

View more
  1 in total

1.  Body distribution of camptothecin solid lipid nanoparticles after oral administration.

Authors:  S Yang; J Zhu; Y Lu; B Liang; C Yang
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.